Cormorant Capital - About the company
Cormorant Capital is an unfunded company based in New York City (United States). It operates as a Real estate fund investing across multiple properties. Cormorant Capital has not raised any funding yet.
Company Details
Real estate fund investing across multiple properties. It is an operator-managed funds focused on a specific real estate sector or geography.
- Website
- cormorant-capital.com
- Social
Key Metrics
Sign up to download Cormorant Capital's company profile
Cormorant Capital's funding and investors
Cormorant Capital has not raised any funding rounds yet.
Cormorant Capital's founders and board of directors
Founder? Claim ProfileCormorant Capital's employee count trend
Cormorant Capital has 5 employees as of Jul 26. Here is Cormorant Capital's employee count trend over the years:
Uncover Cormorant Capital's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cormorant Capital's Investments and acquisitions
Cormorant Capital has not made any acquisitions yet. Cormorant Capital has made 19 investments.Here is the list of latest three $investments:
Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jul 07, 2026 | Investments | 2011 | Philadelphia (United States) | |
Feb 15, 2024 | Investments | 2014 | ||
Nov 03, 2023 | Investments | 2021 | San Francisco (United States) |
Want to know more about where corporates are investing? Sign up today!See all investments by Cormorant Capital
Reports related to Cormorant Capital
Here is the latest report on Cormorant Capital's sector:
News related to Cormorant Capital
Filter this list•
iBio Announces Pricing of $50 Million Public OfferingGlobeNewswire•Aug 19, 2025•iBio, Vestal Point Capital, SilverArc Capital, Adage Capital Management and 5 others
•
•
Edgewise Therapeutics Announces Pricing of $200 Million Underwritten Offering of Common StockPR Newswire•Apr 02, 2025•Edgewise Therapeutics, Braidwell, Cormorant Capital, Driehaus and 14 others
•
Supira Medical raises $120M in Series E funding, completes US feasibility study.PR Newswire•Mar 26, 2025•Supira Medical, Novo Holdings, Sidley, Piper Sandler and 7 others
•
Latigo Biotherapeutics Closes $150M in Series B FinancingFinSMEs•Mar 17, 2025•Latigo Biotherapeutics, Blue Owl, Deep Track Capital, Access Industries and 10 others
•
•
•
Orbis Medicines bags €90 million Series A to develop oral competitors of biologicsOutsourcing-Pharma•Jan 06, 2025•Orbis Medicines, New Enterprise Associates, Lilly, Cormorant Capital and 17 others
•
KALA BIO announces $10.75M private placementSeeking Alpha•Dec 30, 2024•Kala Pharmaceuticals, SR One, Cormorant Capital, Woodline Partners
•
Chroma, Nvelop merge to form nChroma Bio, raising $75M to enter the clinicEndPoints News•Dec 11, 2024•Croma, Nvelop Therapeutics, Chroma Medicine, NChroma Bio and 19 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Cormorant Capital
Explore our recently published companies
- Himsons - Vadodara based, 1988 founded, Unfunded company
- Com2uS Platform Corp - Unfunded company
- Just Print - Unfunded company
